Literature DB >> 1821697

Antigen-independent selection of T15 idiotype during B-cell ontogeny in mice.

M Vakil1, D E Briles, J F Kearney.   

Abstract

Precursors of B cells capable of responding to a T-independent form of phosphorylcholine (PC) in splenic focus assays were detected in the spleens of neonatal mice as early as 4 days after birth. The earliest anti-PC B cells were T15-. T15+ foci-forming B cells were first detected 6 days after birth and expanded rapidly to constitute greater than 80% of the total PC-specific foci by day 10. Injection of heat-killed S. pneumoniae (R36A) into neonatal mice resulted in priming of the antibody response to PC, with an idiotype profile reflecting that of precursors of foci-forming B cells at the time of antigen administration. Priming of 2-day-old mice with 2 x 10(6) and 2 x 10(7) R36A induced a five- and ten-fold increase in the antibody response to phosphorylcholine 6 to 8 weeks later. However, only 10 to 15% of the serum antibodies expressed the normally dominant T15 idiotype. Doses below 2 x 10(5) R36A showed no detectable priming activity. PC-specific hybridomas derived from mice injected with 2 x 10(7) R36A 2 days after birth lacked the idiotypic and molecular characteristics typical of T15+ antibodies. Antibodies to phosphorylcholine, raised by immunization of 6-week-old mice are normally protective against pneumococcal infection. However, serum antibodies from mice treated with R36A 2 days after birth and responding to phosphorylcholine following challenge with R36A at 6 weeks of age failed to protect against deliberate infection with virulent S. pneumoniae. These observations imply that the antigen phosphorylcholine does not play a role in the selective expansion and dominant expression of the T15 idiotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821697      PMCID: PMC2275836          DOI: 10.1155/1991/45352

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  13 in total

Review 1.  Immune recognition of OxLDL in atherosclerosis.

Authors:  J F Kearney
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens.

Authors:  Javier Rangel-Moreno; Juan E Moyron-Quiroz; Damian M Carragher; Kim Kusser; Louise Hartson; Amy Moquin; Troy D Randall
Journal:  Immunity       Date:  2009-05-07       Impact factor: 31.745

3.  Long-term Immunotoxic Effects of Oral Prenatal and Neonatal Atrazine Exposure.

Authors:  Ida Holásková; Meenal Elliott; Kathleen Brundage; Ewa Lukomska; Rosana Schafer; John B Barnett
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 4.  Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones.

Authors:  Gregg J Silverman
Journal:  Ann N Y Acad Sci       Date:  2015-05-18       Impact factor: 5.691

5.  Pulmonary α-1,3-Glucan-Specific IgA-Secreting B Cells Suppress the Development of Cockroach Allergy.

Authors:  Preeyam S Patel; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

Review 6.  Adaptive immunity and adipose tissue biology.

Authors:  Denise A Kaminski; Troy D Randall
Journal:  Trends Immunol       Date:  2010-10       Impact factor: 16.687

Review 7.  Anti-idiotypic antibodies as vaccines against carbohydrate antigens.

Authors:  M A Westerink; M A Apicella
Journal:  Springer Semin Immunopathol       Date:  1993

8.  Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; M Crain
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

9.  Autoimmunity: an infection-related risk?

Authors:  Madeleine W Cunningham
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

10.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.